Synthesis and antibacterial activity of a new series of 3-[3-(substituted phenyl)-1-isonicotinoyl-1H-pyrazol-5-yl]-2H-chromen-2-one derivatives

Archiv der Pharmazie

Volumn 342, Issue 6, 2009, Pages 361-366

  Aragade, Prashant ^a   Maddi, Veeresh ^a   Khode, Suresh ^a   Palkar, Mahesh ^a   Ronad, Pradeepkumar ^a   Mamledesai, Shivalingarao ^a   Satyanarayana, Darbhamulla ^b  

^a KLES's College of Pharmacy   (India)

^b NITTE DEEMED TO BE UNIVERSITY   (India)

Author keywords

Antibacterial activity; Coumarin; Isonicotinic acid hydrazide; Pyrazole

Indexed keywords

3 [3 (2,4 DICHLOROPHENYL) 1 ISONICOTINOYL 1H PYRAZOL 5 YL] 2H CHROMEN 2 ONE; 3 [3 (4 FLUOROPHENYL) 1 ISONICOTINOYL 1H PYRAZOL 5 YL] 2H CHROMEN 2 ONE; 3 [3 (4 HYDROXYPHENYL) 1 ISONICOTINOYL 1H PYRAZOL 5 YL] 2H CHROMEN 2 ONE; AMPICILLIN; CHALCONE DERIVATIVE; CHROMENE DERIVATIVE; COUMARIN DERIVATIVE; ISONIAZID; PYRAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACILLUS SUBTILIS; DRUG STRUCTURE; DRUG SYNTHESIS; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS;

AMPICILLIN; ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; MICROBIAL SENSITIVITY TESTS; PYRAZOLES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 67649386568     PISSN: 03656233     EISSN: 15214184     Source Type: Journal    
DOI: 10.1002/ardp.200800156     Document Type: Article

References (28)

1. K. Coleman, Drug Discov. Today Ther. Strateg., 2004, 1, 455-460.
2. D. Egan, E. O'Kennedy, E. Moran, D. Cox, et al., Drug Metab. Rev. 1990, 22, 503-529.
3. J. N. Modranka, E. Nawrot, J. Graczyk, Eur. J. Med. Chem. 2006, 41, 1301-1309.
4. N. Karali, A. Kocabalkanli, A. Gursoy, O. Ates, Farmaco 2002, 57, 589-593.
5. M. Cacic, M. Trkovnik, F. Cacic, E. H. Schon, Molecules 2006, 11, 134-147.
6. A. Maxwell, Mol. Microbiol. 1993, 9, 681-689.
7. B. Musicki, A. M. Periers, P. Laurin, D. Ferroud, Bioorg. Med. Chem. Lett. 2000, 10, 1695-1699.
8. N. A. Gormley, G. Orphanides, A. Meyer, P. M. Cullis, A. Maxwell, Biochemistry 1996, 35, 5083-5092.
9. I. W. Althaus, L. Dolak, F. Reusser, J. Antibiot. 1988, 41, 373-376.
10. T. D. Penning, J. J. Talley, S. R. Bertenshaw, J. S. Carter, et al., J. Med. Chem. 1997, 40, 1347-1365.
11. A. A. Bekhit, H. M. A. Ashour, Y. S. Abdel Ghany, A. B. Alaa El-Din, A. Baraka, Eur. J. Med. Chem. 2008, 43, 456-463.
12. A. A. Bekhit, H. M. A. Ashour, A. A. Guemei, Arch. Pharm. 2005, 338, 167-174.
13. M. J. Genin, D. A. Allwine, D. J. Anderson, M. R. Barbachyn, et al., J. Med. Chem. 2000, 43, 953-970.
14. A. Tanitame, Y. Oyamada, K. Ofuji, Y. Kyoya, et al., Bioorg. Med. Chem. Lett. 2004, 14, 2857-2862.
15. A. Tanitame, Y. Oyamada, K. Ofuji, M. Fujimoto, et al., J. Med. Chem. 2004, 47, 3693-3696.
16. J. D. Anderson, H. B. Cottam, S. B. Larson, L. D. Nord, et al., J. Heterocycl. Chem. 1990, 27, 439-453.
17. M. Shaharyar, A. A. Siddiqui, M. Ashraf Ali, D. Sriram, P. Yogeeswari, Bioorg. Med. Chem. Lett. 2006, 16, 3947-3949.
18. M. G. Mamolo, D. Zampieri, V. Falagiani, L. Vio, E. Banfi, Farmaco 2001, 56, 593-599.
19. J. L. Avila, M. A. Polegre, A. Avila, R. K. Robins, Comp. Biochem. Physiol. 1986, 83c, 285-289.
20. V. S. Maddi, K. S. Raghu, M. N. A. Rao, J. Pharm. Sci. 1992, 81, 964-966.
21. G. Bolakatti, V. Maddi, S. N. Mamledesai, P. M. Ronad, et al., Arzeimittelforschung 2008, 58, 515-520.
22. P. Ronad, D. Satyanarayana, R. D. Hunshal, V. Maddi, Arch. Pharm. 2008, 341, 696-700.
23. P. Ronad, R. D. Hunshal, D. Satyanarayana, V. Maddi, Arzeim. Forsch. 2008, 58, 641-644.
24. E. Knoevenagel, Chem. Ber. 1898, 31, 2596.
25. th Ed. 2006.
26. M. S. Karthikeyan, B. S. Holla, N. S. Kumari, Eur. J. Med. Chem. 2007, 42, 30-36.
27. P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, R. H. Yolken in Manual of Clinical Microbiology (Eds.: G. L. Woods, J. A. Washington), Am. Soc. Microbiol., Washington, DC, USA, 1995.
28. J. McFarland, J. Am. Med. Assoc. 1907, 14, 1176-1178.